Aktienanalyse zu Qtrex Quantum Ltd (QTEX)QTEXQtrex Quantum Ltd

Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV. It operates in the Healthcare sector.

QTEX is not a strong buy at the moment due to its current price of 0.83, which is significantly below its 200-day simple moving average of 1.358. Additionally, the RSI is at 38.578, indicating the stock is nearing oversold territory but has not yet reversed. The stock has seen a 5-day change of -8.90%, suggesting recent downward momentum, which raises concerns for short-term investors. The main risk is the negative net margin projected for 2025/Q4 at -4574.39%, indicating ongoing financial struggles.